Advanced prostate cancer (metastatic prostate cancer) is a cancer that spreads from the prostate to other parts of the body, and most commonly the bones.
Lutetium-177 PSMA is an innovative new treatment that involves a special radioactive medication being injected into your bloodstream.
Inside your body, the medication seeks out prostate cancer cells and tightly attaches to them. It then precisely delivers a high dose of radiation to destroy the cancer cells.
Usually, most people have four treatments with lutetium-177 PSMA, with three-month breaks between each treatment.
At The London Clinic, your treatment with lutetium-177 PSMA will be overseen by world-leading nuclear medicine and oncology consultants.